Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Circ Res ; 130(1): 80-95, 2022 01 07.
Article in English | MEDLINE | ID: mdl-34809444

ABSTRACT

BACKGROUND: The LDLR (low-density lipoprotein receptor) in the liver is the major determinant of LDL-cholesterol levels in human plasma. The discovery of genes that regulate the activity of LDLR helps to identify pathomechanisms of hypercholesterolemia and novel therapeutic targets against atherosclerotic cardiovascular disease. METHODS: We performed a genome-wide RNA interference screen for genes limiting the uptake of fluorescent LDL into Huh-7 hepatocarcinoma cells. Top hit genes were validated by in vitro experiments as well as analyses of data sets on gene expression and variants in human populations. RESULTS: The knockdown of 54 genes significantly inhibited LDL uptake. Fifteen of them encode for components or interactors of the U2-spliceosome. Knocking down any one of 11 out of 15 genes resulted in the selective retention of intron 3 of LDLR. The translated LDLR fragment lacks 88% of the full length LDLR and is detectable neither in nontransfected cells nor in human plasma. The hepatic expression of the intron 3 retention transcript is increased in nonalcoholic fatty liver disease as well as after bariatric surgery. Its expression in blood cells correlates with LDL-cholesterol and age. Single nucleotide polymorphisms and 3 rare variants of one spliceosome gene, RBM25, are associated with LDL-cholesterol in the population and familial hypercholesterolemia, respectively. Compared with overexpression of wild-type RBM25, overexpression of the 3 rare RBM25 mutants in Huh-7 cells led to lower LDL uptake. CONCLUSIONS: We identified a novel mechanism of posttranscriptional regulation of LDLR activity in humans and associations of genetic variants of RBM25 with LDL-cholesterol levels.


Subject(s)
Nuclear Proteins/metabolism , RNA Splicing , Receptors, LDL/genetics , Cholesterol/metabolism , HEK293 Cells , Hep G2 Cells , Humans , Lipoproteins, LDL/metabolism , Liver/metabolism , Mutation , Nuclear Proteins/genetics , Receptors, LDL/metabolism , Spliceosomes/metabolism
2.
JCI Insight ; 5(1)2020 01 16.
Article in English | MEDLINE | ID: mdl-31830004

ABSTRACT

High-density lipoproteins (HDL) contain hundreds of lipid species and proteins and exert many potentially vasoprotective and antidiabetogenic activities on cells. To resolve structure-function-disease relationships of HDL, we characterized HDL of 51 healthy subjects and 98 patients with diabetes (T2DM), coronary heart disease (CHD), or both for protein and lipid composition, as well as functionality in 5 cell types. The integration of 40 clinical characteristics, 34 nuclear magnetic resonance (NMR) features, 182 proteins, 227 lipid species, and 12 functional read-outs by high-dimensional statistical modeling revealed, first, that CHD and T2DM are associated with different changes of HDL in size distribution, protein and lipid composition, and function. Second, different cellular functions of HDL are weakly correlated with each other and determined by different structural components. Cholesterol efflux capacity (CEC) was no proxy of other functions. Third, 3 potentially novel determinants of HDL function were identified and validated by the use of artificially reconstituted HDL, namely the sphingadienine-based sphingomyelin SM 42:3 and glycosylphosphatidylinositol-phospholipase D1 for the ability of HDL to inhibit starvation-induced apoptosis of human aortic endothelial cells and apolipoprotein F for the ability of HDL to promote maximal respiration of brown adipocytes.


Subject(s)
Coronary Disease/metabolism , Diabetes Mellitus/metabolism , Lipoproteins, HDL/chemistry , Lipoproteins, HDL/metabolism , Atherosclerosis , Biological Assay , Diabetes Mellitus, Type 2/metabolism , Humans , Lipidomics , Lipoproteins/metabolism , Male , Proteomics , Structure-Activity Relationship
3.
Int J Food Microbiol ; 125(2): 182-7, 2008 Jul 15.
Article in English | MEDLINE | ID: mdl-18508146

ABSTRACT

On 15 Swiss poultry farms, broiler flocks, other farm animals, and the environment were examined during consecutive rearing periods to investigate the occurrence and genetic diversity of Campylobacter. Of the 5154 collected samples, 311 (6%) from 14 farms were Campylobacter positive by culture. Amongst the positive samples, 228 tested positive for Campylobacter jejuni and 92 for Campylobacter coli. Positive samples originated from broilers, the broiler houses, cattle, pigs, bantams, laying hens, a horse, and a mouse. Feed, litter, flies, and the supply air to the broiler house tested negative. By flagellin gene typing (fla-RFLP) and pulsed-field gel electrophoresis (PFGE), 917 Campylobacter isolates were genotyped. Additionally, amplified fragment length polymorphism (AFLP) analysis was performed on 15 assorted strains. On eight farms, matching genotypes were isolated from broiler flocks and other farm animals: Certain genotypes from cattle (farms H, K, L, and M), pigs (farms D and P), or laying hens (farm L) were subsequently found in the broiler flocks, whereas other genotypes initially present in the broiler flocks turned up in cattle (farms A, D, and O). These results emphasize the importance of other farm animals on poultry farms for broiler flock colonization. Indications of persistent contamination of the broiler house were evident on four farms (C, D, I, and L) where matching genotypes were detected in consecutive broiler flocks, but not concurrently in other samples. By fla-RFLP, PFGE, and confirmed by AFLP, some genotypes proofed to be identical across different farms.


Subject(s)
Animal Husbandry/methods , Campylobacter Infections/veterinary , Campylobacter/isolation & purification , Chickens/microbiology , Poultry Diseases/microbiology , Animal Husbandry/standards , Animals , Bacterial Typing Techniques , Campylobacter/classification , Campylobacter Infections/epidemiology , Campylobacter Infections/microbiology , Campylobacter Infections/transmission , Campylobacter coli/classification , Campylobacter coli/isolation & purification , Campylobacter jejuni/classification , Campylobacter jejuni/isolation & purification , Cattle/microbiology , Disease Reservoirs/veterinary , Food Contamination/prevention & control , Genotype , Humans , Hygiene , Poultry Diseases/epidemiology , Poultry Diseases/transmission , Prevalence , Swine/microbiology
SELECTION OF CITATIONS
SEARCH DETAIL
...